The label in four points
The short version, from the Ozempic® prescribing information, revised 05/2026.
Stomach effects lead the list
In placebo-controlled trials, nausea affected about 16% to 20% of people on Ozempic®, compared with about 6% on placebo. Vomiting, diarrhea, stomach pain and constipation were the other common effects. Overall, stomach side effects were reported by about 33% to 36% of people on Ozempic® versus about 15% on placebo.
They tend to happen during dose increases
The label says most nausea, vomiting and diarrhea occurred during dose escalation. Ozempic® also slows how fast the stomach empties, which helps explain these effects. Your prescriber sets your schedule and is the right person to ask about how you are feeling.
Most people kept going
About 3% to 4% of people on Ozempic® stopped treatment because of stomach side effects in those trials, compared with 0.4% on placebo. That still matters for the people it affects, which is why the label lists when to seek care.
Some risks are serious
The label carries a boxed warning about thyroid C-cell tumors and lists warnings for pancreatitis, gallbladder problems, kidney injury, low blood sugar and more. Those are covered below, with the symptoms the label says to act on.
Common side effects and how often they happened
The first five rows are the label's Table 1: side effects reported by at least 5% of people on Ozempic®, and more often than on placebo, in the placebo-controlled trials in adults with type 2 diabetes. The other rows come from the label's text on the same trials. The doses in the column headings are the label's trial arms, not a recommendation.
| Side effect | Placebo | Ozempic® 0.5 mg | Ozempic® 1 mg |
|---|---|---|---|
| Nausea | 6.1% | 15.8% | 20.3% |
| Vomiting | 2.3% | 5% | 9.2% |
| Diarrhea | 1.9% | 8.5% | 8.8% |
| Stomach pain | 4.6% | 7.3% | 5.7% |
| Constipation | 1.5% | 5% | 3.1% |
| Indigestion (dyspepsia) | 1.9% | 3.5% | 2.7% |
| Burping (eructation) | 0% | 2.7% | 1.1% |
| Reflux (GERD) | 0% | 1.9% | 1.5% |
| Gallstones (cholelithiasis) | 0% | 1.5% | 0.4% |
Nausea
Nausea was the most common side effect, reported by 15.8% and 20.3% of people at the two doses studied, compared with 6.1% on placebo. It was most often reported while the dose was being increased.
Vomiting and diarrhea
Vomiting was reported by 5% and 9.2% of people on Ozempic®, compared with 2.3% on placebo. Diarrhea was reported by 8.5% and 8.8%, compared with 1.9%. Losing fluids from vomiting or diarrhea can affect the kidneys, which the label lists as a separate warning.
Stomach pain and constipation
Abdominal pain was reported by 7.3% and 5.7% of people on Ozempic®, compared with 4.6% on placebo. Constipation was reported by 5% and 3.1%, compared with 1.5%. Severe stomach pain that does not go away is different, and is covered under serious risks below.
Less common stomach effects
Indigestion, burping, gas, acid reflux and gastritis were each reported by fewer than 5% of people on Ozempic®. Burping, listed on the label as eructation, was reported by 2.7% and 1.1% of people, compared with none on placebo.
Other effects on the label
Fatigue, changes in taste and dizziness were also linked with Ozempic® at frequencies above 0.4%. Heart rate rose by an average of 2 to 3 beats per minute. Gallstones were reported by 1.5% and 0.4% of people at the two doses, and by no one on placebo.
Serious risks on the label
These events are uncommon, but they are why a new or unusual symptom should not always be put down to the medicine.
Boxed warning: thyroid C-cell tumors
In rodent studies, semaglutide caused thyroid C-cell tumors, and it is unknown whether it does this in people. Ozempic® should not be used by anyone with a personal or family history of medullary thyroid carcinoma (MTC) or with MEN 2. The label says to report a lump or swelling in the neck, trouble swallowing, hoarseness or shortness of breath.
Pancreatitis
Acute pancreatitis has been reported with GLP-1 medicines, including Ozempic®. The label describes persistent severe stomach pain, sometimes spreading to the back, with or without vomiting. That symptom needs prompt medical attention.
Gallbladder problems
The label lists acute gallbladder disease, including gallstones and inflammation of the gallbladder. Pain in the upper stomach, fever, yellowing of the skin or eyes, or clay-colored stools are signs to report.
Kidney injury from fluid loss
Severe vomiting or diarrhea can cause dehydration, and the label warns this can lead to acute kidney injury. Staying in touch with your prescriber when stomach effects are strong is part of the label's guidance.
Low blood sugar, eye changes and allergic reactions
Low blood sugar is more likely when Ozempic® is used with insulin or a sulfonylurea. In the trial that added Ozempic® to basal insulin, blood sugar confirmed at or below 56 mg/dL with symptoms, or severe low blood sugar, was reported by 8.3% to 10.7% of people, compared with 5.3% on placebo. The label also lists diabetic retinopathy complications and serious allergic reactions, and notes a risk of food or liquid entering the lungs during anesthesia or deep sedation, so tell your care team you take Ozempic® before any procedure.
When to call your prescriber or get emergency care
This list follows the warnings and Medication Guide in the Ozempic® label. It is not a complete list and it is not medical advice: if something feels wrong, call.
Get emergency help for
Signs of a serious allergic reaction, such as swelling of the face, lips, tongue or throat, trouble breathing or a very fast heartbeat, need emergency care. So does severe stomach pain that will not go away.
Call your prescriber about
Contact your prescriber about any of these:
- Nausea, vomiting or diarrhea that is severe or will not go away, or signs of dehydration.
- Pain in the upper stomach, fever, yellowing of the skin or eyes, or clay-colored stools, which can be gallbladder signs.
- Shakiness, sweating, dizziness, a fast heartbeat, hunger, headache, blurred vision, confusion or irritability, which can mean low blood sugar, especially with insulin or a sulfonylurea.
- Any change in your vision, if you have type 2 diabetes.
- A lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.
Before any procedure
Tell the doctors and care team that you take Ozempic® before surgery or any procedure that uses anesthesia or sedation. The label asks patients to share this so the team can plan.
Questions about your dose
Questions about your dose, schedule or a missed shot belong with your prescriber, and your label has the official missed-dose instructions. This page does not give dosing advice.
How to report a side effect
The label gives two contacts for reporting a suspected side effect: Novo Nordisk at 1-888-693-6742, or the FDA's MedWatch program at 1-800-FDA-1088.
Why stomach effects are so common
Understanding why an effect happens helps you describe it accurately to your prescriber.
Slower stomach emptying
The label states that Ozempic® delays gastric emptying, meaning food stays in the stomach longer. That slower emptying is linked with fullness, nausea and other stomach effects.
Dose increases are the peak time
Most nausea, vomiting and diarrhea in the trials happened during dose escalation. In a trial comparing two higher doses, stomach effects were slightly more frequent at the higher dose: 34% on 2 mg versus 30.8% on 1 mg.
Weekly dosing means effects can linger
Semaglutide has a half-life of about 1 week, so each dose stays active for days. That is one reason some people notice symptoms follow a pattern across the week. The semaglutide half-life calculator shows what a 1-week half-life looks like.
From the makers of this guide
Keep a simple side effect log
The label gives trial averages. Your prescriber needs your version: what you felt, how strong it was, and when.
- 01
Note what, when and how strong
The side-effect tracker has built-in GLP-1 symptoms grouped by area, such as injection site, digestive and head and nerves, plus your own, each saved by day with how severe it was. A short daily check-in asks about food noise, side effects and mood, and you can add questions such as energy and sleep.
- 02
Symptoms beside your shot days
Your side-effect trend chart sits on the Dose tab beside your Ozempic® shot history and estimated level chart, so a pattern like nausea on the day after each shot is easy to spot.
- 03
Meals you can look back on
Log meals by photo scan, barcode or search in Nutrition, then look back to notice which foods tend to sit well on harder days.
- 04
See which weeks felt different
After a few weeks, the trend chart shows which stretches were rough and which were easy, which turns a vague feeling into something specific you can describe.
Bring your log to your next appointment
A side effect log does the most good in the conversation with your prescriber.
A report your prescriber can read in a minute
Pep AI builds a PDF report of your doses, injection sites, weight and daily meal totals. Show it on your phone or send it ahead of the visit.
Questions worth asking
Ask whether a symptom pattern is expected, what to watch for and when to call between visits. Your prescriber decides what, if anything, should change.
Keep going between visits
Logging takes a few seconds a day once the routine is set, and the next report is ready whenever the next appointment comes around.
More reading on Pep AI
For a broader overview, read GLP-1 side effects. For nausea in particular, GLP-1 nausea covers what the labels say, and the Ozempic® tracker shows how shot logging works.
Key takeaways
- Nausea was reported by 15.8% to 20.3% of adults on Ozempic® in type 2 diabetes trials, versus 6.1% on placebo.
- Most nausea, vomiting and diarrhea happened during dose escalation.
- About 3% to 4% stopped Ozempic® because of stomach effects, versus 0.4% on placebo.
- Ozempic® carries the boxed thyroid C-cell tumor warning, and its label lists pancreatitis, gallbladder problems, kidney injury and low blood sugar.
- Dose, schedule and missed-dose questions belong with your prescriber and your label.
Know which side effects are yours.
Pep AI logs your Ozempic® shots, symptoms with severity, meals and weight, and makes a PDF of your doses, sites, weight and meal totals. Download Pep AI on iPhone or Android.
Frequently asked questions
Keep reading
Sources
This page summarizes the Ozempic® prescribing information (revised 05/2026). It is general information, not medical advice, and does not replace your prescriber or pharmacist. Pep AI is not affiliated with or endorsed by Novo Nordisk. If a symptom is severe, getting worse or worrying you, contact your healthcare provider. In an emergency, call 911.
Published by the Pep AI team · Updated November 2026